28
Participants
Start Date
October 17, 2019
Primary Completion Date
February 12, 2021
Study Completion Date
February 4, 2022
SHP674
SHP674: powder for solution for injection, IV (administered by 1 to 2 hours of drip infusion), dose determination : if BSA ≥0.6 m\^2: 2500 IU/m\^2 every 14 days if BSA \<0.6 m\^2: 82.5 IU/kg every 14 days
Kagoshima University Hospital Department of Pediatrics, Kagoshima
Kobe Children's Hospital Department of Hematology/Oncology, Kobe
Nagoya Medical Center Department of Pediatrics, Nagoya
Niigata Cancer Center Hospital, Niigata
Saitama Children's Medical Center Department of Hematology/Oncology, Saitama
Sapporo Hokuyu Hospital Department of Pediatrics and Adolescent Medicine, Sapporo
National Cancer Center Hospital Department of Pediatric Oncology, Tokyo
St. Luke's International Hospital Department of Pediatrics, Tokyo
Kyowa Kirin Co., Ltd.
INDUSTRY
ADIR, a Servier Group company
INDUSTRY
Institut de Recherches Internationales Servier
OTHER